Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics

Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics

Metabolic phenotyping is poised as a powerful and promising tool for biomarker discovery in inherited metabolic diseases. However, few studies applied this approach to mcopolysaccharidoses (MPS). Thus, this innovative functional approach may unveil comprehensive impairments in MPS biology. This stud...

Full description

Bibliographic Details
Main Authors:	Abdellah Tebani, Lenaig Abily-Donval, Isabelle Schmitz-Afonso, Monique Piraud, Jérôme Ausseil, Farid Zerimech, Carine Pilon, Tony Pereira, Stéphane Marret, Carlos Afonso, Soumeya Bekri
Format:	Article
Language:	English
Published:	MDPI AG 2019-01-01
Series:	International Journal of Molecular Sciences
Subjects:	metabolomics inherited metabolic diseases lysosomal storage diseases mucopolysaccharidosis type VI Maroteaux–Lamy syndrome mass spectrometry
Online Access:	https://www.mdpi.com/1422-0067/20/2/446

Similar Items

A Case Report of Mucopolysaccharidosis Type VI
by: SJ Hosseini, et al.
Published: (2018-12-01)

Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
by: Aneesh Karir, et al.
Published: (2018-06-01)

Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis
by: Abdellah Tebani, et al.
Published: (2018-09-01)

Mutational analysis of ARSB gene in mucopolysaccharidosis type VI: identification of three novel mutations in Iranian patients
by: Nasrin Malekpour, et al.
Published: (2018-09-01)

Atlantoaxial instability in a case of Maroteaux–Lamy syndrome
by: Abhidha Shah, et al.
Published: (2021-01-01)

Mucopoly saccharidosis type maroteaux-lamy, a case report
by: A.R. Alaee, et al.
Published: (2007-01-01)

Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance
by: Mehmet Umut Akyol, et al.
Published: (2019-05-01)

Double valve replacement in a patient with Maroteaux – Lamy syndrome as an ultimate team challenge
by: Alexandros Agron Demis, et al.
Published: (2021-05-01)

Development of a fluorometric microtiter plate-based enzyme assay for arylsulfatase B (MPS VI) using dried blood spots
by: Anirudh J. Ullal, et al.
Published: (2014-01-01)

Mutations in ARSB in MPS VI patients in India
by: Juby Mathew, et al.
Published: (2015-09-01)

Surgical treatment of craniovertebral stenosis in patients with mucopolysaccharidosis type I, II, and VI
by: Sergey P. Mironov, et al.
Published: (2018-12-01)

Mucopolysaccharidosis type VI on enzyme replacement therapy since infancy: Six years follow-up of four children
by: Dafne D.G. Horovitz, et al.
Published: (2015-12-01)

Musculoskeletal manifestations of mucopolysaccharidosis type VI and effects of enzyme replacement therapy
by: Marucha Jolanta, et al.
Published: (2012-04-01)

Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
by: Abdellah Tebani, et al.
Published: (2016-05-01)

Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
by: Roberto Giugliani, et al.
Published: (2010-01-01)

Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation
by: Rachel Sayuri Honjo, et al.
Published: (2020-02-01)

Mukopolisacharydoza typu VI (choroba Maroteaux-Lamy’ego) – opis przypadku
by: Agnieszka Jurecka, et al.
Published: (2010-09-01)

Kostno-stawowa manifestacja mukopolisacharydozy typu VI (choroby Maroteaux-Lamy’ego)
by: Agnieszka Jurecka, et al.
Published: (2011-08-01)

Alder-Reilly Anomaly in Patients with Mucopolysaccharidosis VI
by: Taiane Alves Vieira, et al.
Published: (2008-09-01)

Triagem neonatal para mucopolissacaridose tipo VI (Síndrome de Maroteux-Lamy) em uma região com alta incidência da doença
by: Bender, Fernanda
Published: (2012)

Triagem neonatal para mucopolissacaridose tipo VI (Síndrome de Maroteux-Lamy) em uma região com alta incidência da doença
by: Bender, Fernanda
Published: (2012)

Triagem neonatal para mucopolissacaridose tipo VI (Síndrome de Maroteux-Lamy) em uma região com alta incidência da doença
by: Bender, Fernanda
Published: (2012)

Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era
by: Abdellah Tebani, et al.
Published: (2016-07-01)

Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
by: Li Ou, et al.
Published: (2016-09-01)

Long-term clinical course of a patient with mucopolysaccharidosis type IIIB
by: Ja Hye Kim, et al.
Published: (2016-11-01)

Roentgenographic diagnosis of mucopolysaccharidosis with particular reference to Morquio syndrome
by: umesh chandra parashari, et al.
Published: (2012-02-01)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
by: Valeria De Pasquale, et al.
Published: (2020-02-01)

Análisis genético y molecular del síndrome de Maroteaux-Lamy
by: Garrido Fernández, Elena
Published: (2008)

Clinical, Biochemical and Molecular Characteristics of Fifteen Patients with Mucopolysaccharidosis Type II in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI—Indirect Proof of Principle on Its Pathogenicity
by: Maria Francisca Coutinho, et al.
Published: (2020-01-01)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

Mucopolysaccharidosis VII in Brazil: natural history and clinical findings
by: Roberto Giugliani, et al.
Published: (2021-05-01)

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease
by: Abdellah Tebani, et al.
Published: (2020-05-01)

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment
by: Christian J. Hendriksz, et al.
Published: (2015-12-01)

AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains
by: Michaël Hocquemiller, et al.
Published: (2020-06-01)

Non-Neuropathic Form of Mucopolysaccharidosis Type II: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2021-03-01)

Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
by: Tapiero-Rodriguez SM, et al.
Published: (2018-04-01)

Mucopolysaccharidosis-Plus Syndrome
by: Filipp Vasilev, et al.
Published: (2020-01-01)

Mucopolysaccharidosis Type II in the Practice of the Physician
by: I.Y. Vatanskaya, et al.
Published: (2016-09-01)

Cannot write session to /tmp/vufind_sessions/sess_7t8j0ojtkh39dvhvofolos2jbm